{"eventGroups":[{"deathsNumAffected":2,"deathsNumAtRisk":11,"description":"Patients receive pembrolizumab IV over 30 minutes and pemetrexed disodium IV over 10 minutes on day 1. Treatment with pembrolizumab repeats every 21 days for up to 35 cycles (2 years) in the absence of disease progression or unacceptable toxicity. Cycles of pemetrexed disodium repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients who had stable disease, partial response, or complete response after completion of 35 cycles of pembrolizumab, may continue pembrolizumab for an additional 17 cycles (1 year) in the absence of disease progression or unacceptable toxicity. Patients additionally undergo blood sample collection, CT, PET/CT or MRI and may also undergo PSMA PET on study.","id":"EG000","otherNumAffected":10,"otherNumAtRisk":11,"seriousNumAffected":3,"seriousNumAtRisk":11,"title":"Cohort A (Adenoid Cystic Carcinoma)"},{"deathsNumAffected":0,"deathsNumAtRisk":9,"description":"Patients receive pembrolizumab IV over 30 minutes and pemetrexed disodium IV over 10 minutes on day 1. Treatment with pembrolizumab repeats every 21 days for up to 35 cycles (2 years) in the absence of disease progression or unacceptable toxicity. Cycles of pemetrexed disodium repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients who had stable disease, partial response, or complete response after completion of 35 cycles of pembrolizumab, may continue pembrolizumab for an additional 17 cycles (1 year) in the absence of disease progression or unacceptable toxicity. Patients additionally undergo blood sample collection, CT, PET/CT or MRI and may also undergo PSMA PET on study.","id":"EG001","otherNumAffected":9,"otherNumAtRisk":9,"seriousNumAffected":4,"seriousNumAtRisk":9,"title":"Cohort A1 (ACC Patients Enrolled Starting With MCCC Amendment"},{"deathsNumAffected":2,"deathsNumAtRisk":25,"description":"Patients receive pembrolizumab IV over 30 minutes and pemetrexed disodium IV over 10 minutes on day 1. Treatment with pembrolizumab repeats every 21 days for up to 35 cycles (2 years) in the absence of disease progression or unacceptable toxicity. Cycles of pemetrexed disodium repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients who had stable disease, partial response, or complete response after completion of 35 cycles of pembrolizumab, may continue pembrolizumab for an additional 17 cycles (1 year) in the absence of disease progression or unacceptable toxicity. Patients additionally undergo blood sample collection, CT, PET/CT or MRI and may also undergo PSMA PET on study.","id":"EG002","otherNumAffected":24,"otherNumAtRisk":25,"seriousNumAffected":8,"seriousNumAtRisk":25,"title":"Cohort B (Non-adenoid Cystic Carcinoma)"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":11,"numEvents":8},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":11,"numAtRisk":25,"numEvents":15}],"term":"Anemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":11,"numEvents":18},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":4,"numAtRisk":25,"numEvents":22}],"term":"Blood and lymph sys disorders - Oth Spec"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Sinus bradycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Sinus tachycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Ear pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Vertigo"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Hyperparathyroidism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":4}],"term":"Hyperthyroidism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":4,"numAtRisk":25,"numEvents":6}],"term":"Hypothyroidism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":4},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":2}],"term":"Blurred vision"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":4},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Eye disorders - Other, specify"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Eye pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Vision decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":2},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Watering eyes"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":4,"numAtRisk":25,"numEvents":4}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":4,"numAtRisk":9,"numEvents":5},{"groupId":"EG002","numAffected":6,"numAtRisk":25,"numEvents":9}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Dry mouth"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Esophagitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Gastroesophageal reflux disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Mucositis oral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":11,"numEvents":12},{"groupId":"EG001","numAffected":3,"numAtRisk":9,"numEvents":11},{"groupId":"EG002","numAffected":12,"numAtRisk":25,"numEvents":24}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Oral pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":5,"numAtRisk":25,"numEvents":7}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":5}],"term":"Edema limbs"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":4}],"term":"Facial pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":11,"numEvents":26},{"groupId":"EG001","numAffected":9,"numAtRisk":9,"numEvents":30},{"groupId":"EG002","numAffected":19,"numAtRisk":25,"numEvents":55}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":9,"numEvents":3},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Gen disord and admin site conds-Oth spec"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Non-cardiac chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":2}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Cholecystitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Conjunctivitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Bruising"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":11,"numEvents":6},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":5,"numAtRisk":25,"numEvents":6}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":11,"numEvents":5},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":4}],"term":"Alkaline phosphatase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":11,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":3}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":11,"numEvents":10},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":6,"numAtRisk":25,"numEvents":18}],"term":"Creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"ECG QT corrected interval prolonged"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"INR increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":11,"numEvents":11},{"groupId":"EG001","numAffected":7,"numAtRisk":9,"numEvents":21},{"groupId":"EG002","numAffected":19,"numAtRisk":25,"numEvents":47}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Thyroid stimulating hormone increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":5},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":2}],"term":"White blood cell decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":9,"numEvents":3},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Anorexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":11}],"term":"Blood bicarbonate decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":9}],"term":"Hypercalcemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":11,"numEvents":9},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":5,"numAtRisk":25,"numEvents":8}],"term":"Hyperglycemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Hyperkalemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Hypernatremia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Hypoalbuminemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":5},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Hypomagnesemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Hyponatremia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":6}],"term":"Hypophosphatemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":2}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":3}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Generalized muscle weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Muscle weakness lower limb"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Musculoskeletal, conn tissue - Oth spec"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":3}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Trismus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Dysarthria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":9,"numEvents":4},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":2}],"term":"Dysgeusia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":5}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Peripheral motor neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Recurrent laryngeal nerve palsy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":2}],"term":"Anxiety"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Depression"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":25,"numEvents":3}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":3}],"term":"Chronic kidney disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Urinary frequency"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":9,"numEvents":3},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":11,"numEvents":5},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Hoarseness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":3,"numAtRisk":9,"numEvents":3},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":2}],"term":"Resp, thoracic, mediastinal - Oth spec"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Sleep apnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Erythema multiforme"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":4}],"term":"Hyperhidrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":4}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":11,"numEvents":3},{"groupId":"EG001","numAffected":5,"numAtRisk":9,"numEvents":8},{"groupId":"EG002","numAffected":6,"numAtRisk":25,"numEvents":9}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Hot flashes"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":11,"numEvents":16},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":4},{"groupId":"EG002","numAffected":12,"numAtRisk":25,"numEvents":24}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Lymphedema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Thromboembolic event"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Thrombotic thrombocytopenic purpura"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Heart failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Blurred vision"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Oral cavity fistula"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Upper gastrointestinal hemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":25,"numEvents":2}],"term":"Disease progression"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders and administration site conditions","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Gen disord and admin site conds-Oth spec"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Infections and infestations - Oth spec"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Thrush"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Hypokalemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Transient ischemic attacks"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Hematuria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":9,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":25,"numEvents":0}],"term":"Sore throat"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":9,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":25,"numEvents":1}],"term":"Thromboembolic event"}],"timeFrame":"Patient mortality was followed for 3 years and adverse events were followed for 27 months"}